These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 17447410)
1. Levodopa in the treatment of Parkinson's disease. Fahn S J Neural Transm Suppl; 2006; (71):1-15. PubMed ID: 17447410 [TBL] [Abstract][Full Text] [Related]
2. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Fahn S; J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436 [TBL] [Abstract][Full Text] [Related]
3. A new look at levodopa based on the ELLDOPA study. Fahn S J Neural Transm Suppl; 2006; (70):419-26. PubMed ID: 17017562 [TBL] [Abstract][Full Text] [Related]
4. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. Parkinson Study Group JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889 [TBL] [Abstract][Full Text] [Related]
5. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study. Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL; CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study). Poewe WH; Deuschl G; Gordin A; Kultalahti ER; Leinonen M; Acta Neurol Scand; 2002 Apr; 105(4):245-55. PubMed ID: 11939936 [TBL] [Abstract][Full Text] [Related]